ENDOTHELIUM-DERIVED RELAXING FACTOR RELEASED FROM CULTURED CELLS: DIFFERENTIATION FROM NITRIC OXIDE
- 1 February 1988
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 15 (2) , 83-92
- https://doi.org/10.1111/j.1440-1681.1988.tb01049.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Mechanism of action of some inhibitors of endothelium-derived relaxing factor.Proceedings of the National Academy of Sciences, 1986
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- Release and properties of endothelium‐derived relaxing factor (EDRF) from endothelial cells in cultureJournal of Cellular Physiology, 1985
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.Circulation Research, 1983
- Anoxia and endothelium‐dependent reactivity of the canine femoral artery.The Journal of Physiology, 1983
- The release and fate of vaso‐active hormones in the circulationBritish Journal of Pharmacology, 1969
- The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobinThe Journal of Physiology, 1957